SCHEMBL47271

SCHEMBL47271

CC1(C)CC(c2cc(F)cc(N3CCOCC3)c2)Nc2ccc(C(=O)N3CCC(C(C)(C)O)C3)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAG1 P54619 1/20 0.42
PRKAA1 Q13131 1/20 0.42
PRKAB1 Q9Y478 1/20 0.42
HSD11B1 P28845 1/20 0.38
GHSR Q92847 1/20 0.36
MGLL Q99685 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
AKT1 P31749 1/20 0.33
PIK3CA P42336 1/20 0.33
IDH1 O75874 1/20 0.33
FAAH O00519 1/20 0.33
BCL9 O00512 3/20 0.33
CTNNB1 P35222 3/20 0.33
PDK2 Q15119 3/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CG P48736 1/20 0.33
KDM5A P29375 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL44971 0.89 MEN1 (0.41) PRKAG1PRKAA1PRKAB1GHSRMGLL
SCHEMBL45124 0.89 PRKAG1 (0.52) PRKAG1PRKAA1PRKAB1HSD11B1GHSR
SCHEMBL11029216 0.85 PRKAG1 (0.41) PRKAG1PRKAA1PRKAB1HSD11B1KDM4E
SCHEMBL42376 0.84 PRKAG1 (0.42) PRKAG1PRKAA1PRKAB1HSD11B1KDM4E
SCHEMBL45267 0.84 PRKAG1 (0.46) PRKAG1PRKAA1PRKAB1HSD11B1GHSR
SCHEMBL11025816 0.81 PRKAG1 (0.40) PRKAG1PRKAA1PRKAB1MGLLKDM4E
SCHEMBL11940877 0.79 SCN9A (0.39) PRKAG1PRKAA1PRKAB1MAPTAKT1
SCHEMBL45015 0.79 MAPT (0.40) PRKAG1PRKAA1PRKAB1MEN1MAPT
SCHEMBL11027687 0.79 PRKAG1 (0.38) PRKAG1PRKAA1PRKAB1KDM4EMAPT
SCHEMBL45014 0.78 HTR1A (0.39) PRKAG1PRKAA1PRKAB1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004218-A1 NOVEL TETRAHYDRO-QUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2012-01-05 US disclosed
US-20120004218-A1 NOVEL TETRAHYDRO-QUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2012-01-05 US disclosed
WO-2012001020-A1 NOVEL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004218-A1 NOVEL TETRAHYDRO-QUINOLINE DERIVATIVES GPR119, PRKAB1, PRKAG1 PRKAG1 3/4885PRKAA1 5/4885PRKAB1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.